Exact Mass: 361.0995

Exact Mass Matches: 361.0995

Found 342 metabolites which its exact mass value is equals to given mass value 361.0995, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Ofloxacin

7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0⁵,¹³]trideca-5(13),6,8,11-tetraene-11-carboxylic acid

C18H20FN3O4 (361.1438)


Ofloxacin is only found in individuals that have used or taken this drug. It is a synthetic fluoroquinolone (fluoroquinolones) antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication. [PubChem]Ofloxacin acts on DNA gyrase and toposiomerase IV, enzymes which, like human topoisomerase, prevents the excessive supercoiling of DNA during replication or transcription. By inhibiting their function, the drug thereby inhibits normal cell division. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3073 CONFIDENCE standard compound; INTERNAL_ID 4075 CONFIDENCE standard compound; INTERNAL_ID 1033

   

Fenoxaprop-ethyl

ethyl 2-{4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy}propanoate

C18H16ClNO5 (361.0717)


D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

   

Glucoputranjivin

1-Methylethyl glucosinolate

C10H19NO9S2 (361.0501)


An alkylglucosinolic acid that consists of 1-thio-beta-D-glucopyranose attached to a 2-methyl-N-(sulfooxy)propanimidoyl group at the anomeric sulfur.

   

Pyriminobac-methyl

methyl 2-(4,6-dimethoxypyrimidin-2-yl)oxy-6-(N-methoxy-C-methylcarbonimidoyl)benzoate

C17H19N3O6 (361.1274)


Pyriminobac-methyl is a herbicide used on rice. Herbicide used on rice

   

Levofloxacin

(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0^{5,13}]trideca-5(13),6,8,11-tetraene-11-carboxylic acid

C18H20FN3O4 (361.1438)


Levofloxacin is a synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication. Levofloxacin is marketed by Ortho-McNeil under the trade name Levaquin. Chemically, levofloxacin is the S-enantiomer (L-isomer) of ofloxacin. -- Wikipedia [HMDB] Levofloxacin is a synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication. Levofloxacin is marketed by Ortho-McNeil under the trade name Levaquin. Chemically, levofloxacin is the S-enantiomer (L-isomer) of ofloxacin. -- Wikipedia. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   
   

bisacodyl

bisacodyl

C22H19NO4 (361.1314)


A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation > A06AB - Contact laxatives A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation > A06AG - Enemas C78276 - Agent Affecting Digestive System or Metabolism > C29697 - Laxative D005765 - Gastrointestinal Agents > D002400 - Cathartics D005765 - Gastrointestinal Agents > D054368 - Laxatives Bisacodyl is a stimulant laxative agent that works directly on the colon to produce a bowel movement. Bisacodyl increases the secretion of PGE2 by direct activation of colon macrophages. PGE2 acts as a paracrine factor and decreases the expression of AQP3 in the colon, which inhibits water transfer from the luminal to the vascular side and leads to a laxative effect[1].

   

5-Hydroxyomeprazole

(4-methoxy-6-{[(6-methoxy-1H-1,3-benzodiazol-2-yl)sulfinyl]methyl}-5-methylpyridin-3-yl)methanol

C17H19N3O4S (361.1096)


5-Hydroxyomeprazole is only found in individuals that have used or taken Omeprazole. 5-Hydroxyomeprazole is a metabolite of Omeprazole. 5-hydroxyomeprazole belongs to the family of Sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety.

   

Omeprazole sulfone

6-Methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulphonyl]-1H-1,3-benzodiazole

C17H19N3O4S (361.1096)


Omeprazole sulfone is only found in individuals that have used or taken Omeprazole. Omeprazole sulfone is a metabolite of Omeprazole. Omeprazole sulfone belongs to the family of Sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety.

   

Bezafibrate

2-(4-{2-[(4-chlorophenyl)formamido]ethyl}phenoxy)-2-methylpropanoic acid

C19H20ClNO4 (361.1081)


Bezafibrate is only found in individuals that have used or taken this drug. It is an antilipemic agent that lowers cholesterol and triglycerides. It decreases low density lipoproteins and increases high density lipoproteins. [PubChem]Like the other fibrates, bezafibrate is an agonist of PPARα; some studies suggest it may have some activity on PPARγ and PPARδ as well. C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites Bezafibrate is an agonist of PPAR, with EC50s of 50 μM, 60 μM, 20 μM for human PPARα, PPARγ and PPARδ, and 90 μM, 55 μM, 110 μM for murine PPARα, PPARγ and PPARδ, respectively; Bezafibrate is used as an hypolipidemic agent.

   

De-O-methylsimmondsin

2-[(1E)-2,4-dihydroxy-3-methoxy-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexylidene]acetonitrile

C15H23NO9 (361.1373)


De-O-methylsimmondsin is found in coffee and coffee products. De-O-methylsimmondsin is a constituent of jojoba meal. Constituent of jojoba meal. Demethylsimmondsin is found in coffee and coffee products, fats and oils, and nuts.

   

3-Hydroxyomeprazole

(4-Methoxy-2-{[(6-methoxy-1H-1,3-benzodiazol-2-yl)sulphinyl]methyl}-5-methylpyridin-3-yl)methanol

C17H19N3O4S (361.1096)


3-Hydroxyomeprazole is only found in individuals that have used or taken Omeprazole. 3-Hydroxyomeprazole is a metabolite of Omeprazole. 3-hydroxyomeprazole belongs to the family of Sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety.

   

Avenanthramide A2

(2E)-N-[2-(Dihydroxymethyl)-4-hydroxy-5-methoxyphenyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidate

C18H19NO7 (361.1161)


Avenanthramide A2 is a polyphenol compound found in foods of plant origin (PMID: 20428313)

   

Aminomethyl fluorescein

8-(aminomethyl)-3,6-dihydroxy-3H-spiro[2-benzofuran-1,9-xanthene]-3-one

C21H15NO5 (361.095)


   

Benoxathian

[(2,3-dihydro-1,4-benzoxathiin-2-yl)methyl][2-(2,6-dimethoxyphenoxy)ethyl]amine

C19H23NO4S (361.1348)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

Bisacodyl

4-{[4-(acetyloxy)phenyl](pyridin-2-yl)methyl}phenyl acetic acid

C22H19NO4 (361.1314)


A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation > A06AB - Contact laxatives A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation > A06AG - Enemas C78276 - Agent Affecting Digestive System or Metabolism > C29697 - Laxative D005765 - Gastrointestinal Agents > D002400 - Cathartics D005765 - Gastrointestinal Agents > D054368 - Laxatives Bisacodyl is a stimulant laxative agent that works directly on the colon to produce a bowel movement. Bisacodyl increases the secretion of PGE2 by direct activation of colon macrophages. PGE2 acts as a paracrine factor and decreases the expression of AQP3 in the colon, which inhibits water transfer from the luminal to the vascular side and leads to a laxative effect[1].

   

Ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-enecarboxylate

1-Cyclohexene-1-carboxylic acid, 6-[[(2-chloro-4-fluorophenyl)amino]sulfonyl]-, ethyl ester

C15H17ClFNO4S (361.0551)


   

Fostedil

Diethyl {[4-(1,3-benzothiazol-2-yl)phenyl]methyl}phosphonic acid

C18H20NO3PS (361.0901)


   

metampicillin

6-{[1-hydroxy-2-(methylideneamino)-2-phenylethylidene]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

C17H19N3O4S (361.1096)


   

Nitroflurbiprofen

4-(Nitrooxy)butyl 2-fluoro-alpha-methyl-(1,1-biphenyl)-4-acetic acid

C19H20FNO5 (361.1325)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor

   

Ptemc

3-(2-(Phenylthio)ethyl)-5-methoxycarbonyl-4-methyl-2,6-dimethyl-1,4-dihydropyridine-3-carboxylate

C19H23NO4S (361.1348)


   

5-Methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazol-4-ol

6-Methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulphinyl]-1H-1,3-benzodiazol-7-ol

C17H19N3O4S (361.1096)


   

SPARSOMYCIN

N-[1-hydroxy-3-(methylsulfanyl)methanesulfinylpropan-2-yl]-3-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)prop-2-enamide

C13H19N3O5S2 (361.0766)


   

Pyriminobac-methyl, (Z)-

Methyl 2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-6-[1-(methoxyimino)ethyl]benzoic acid

C17H19N3O6 (361.1274)


   

1-[(4-Aminophenyl)methyl]-3-(3-nitrophenyl)imidazo[4,5-b]pyridin-2-one

1-[(4-aminophenyl)methyl]-3-(3-nitrophenyl)-1H,2H,3H-imidazo[4,5-b]pyridin-2-one

C19H15N5O3 (361.1175)


   

Levofloxacin

Levofloxacin

C18H20FN3O4 (361.1438)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3239 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   
   

Cyclomegistine

Cyclomegistine

C18H19NO7 (361.1161)


   
   

Leptoclinidamine B

Leptoclinidamine B

C16H19N5O5 (361.1386)


   
   

Dihydroarcyriarubin C

trans-Dihydroarcyriarubin C

C20H15N3O4 (361.1063)


   
   

Orisuaveoline B

Orisuaveoline B

C20H15N3O4 (361.1063)


   

n-Propyl glucosinolate

n-Propyl glucosinolate

C10H19NO9S2 (361.0501)


   

ofloxacin

ofloxacin

C18H20FN3O4 (361.1438)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic CASMI2013 Challenge_16 MS2 data, retention time = 3.7 min CASMI2013 Challenge_16 MS1 data, retention time = 3.7 min

   

SAR102608

SAR102608

C20H16FN5O (361.1339)


CONFIDENCE standard compound; INTERNAL_ID 1359; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4212; ORIGINAL_PRECURSOR_SCAN_NO 4209 CONFIDENCE standard compound; INTERNAL_ID 1359; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4285; ORIGINAL_PRECURSOR_SCAN_NO 4280 CONFIDENCE standard compound; INTERNAL_ID 1359; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4295; ORIGINAL_PRECURSOR_SCAN_NO 4294 CONFIDENCE standard compound; INTERNAL_ID 1359; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4294; ORIGINAL_PRECURSOR_SCAN_NO 4293 CONFIDENCE standard compound; INTERNAL_ID 1359; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4304; ORIGINAL_PRECURSOR_SCAN_NO 4303 CONFIDENCE standard compound; INTERNAL_ID 1359; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4291; ORIGINAL_PRECURSOR_SCAN_NO 4288 CONFIDENCE standard compound; INTERNAL_ID 1359; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8805; ORIGINAL_PRECURSOR_SCAN_NO 8804 CONFIDENCE standard compound; INTERNAL_ID 1359; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8813; ORIGINAL_PRECURSOR_SCAN_NO 8811 CONFIDENCE standard compound; INTERNAL_ID 1359; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8820; ORIGINAL_PRECURSOR_SCAN_NO 8818 CONFIDENCE standard compound; INTERNAL_ID 1359; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8838; ORIGINAL_PRECURSOR_SCAN_NO 8833 CONFIDENCE standard compound; INTERNAL_ID 1359; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8848; ORIGINAL_PRECURSOR_SCAN_NO 8844 CONFIDENCE standard compound; INTERNAL_ID 1359; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8849; ORIGINAL_PRECURSOR_SCAN_NO 8848

   

Maybridge4_004692

Maybridge4_004692

C15H9F6N3O (361.065)


   
   

4-Amino-2-{[5-(2-furyl)-4-phenyl-4H-1,2,4-triazol-3-yl]sulfanyl}-5-pyrimidinecarbonitrile

4-Amino-2-{[5-(2-furyl)-4-phenyl-4H-1,2,4-triazol-3-yl]sulfanyl}-5-pyrimidinecarbonitrile

C17H11N7OS (361.0746)


   
   

Maybridge4_004058

Maybridge4_004058

C19H15N5OS (361.0997)


   
   

N-(1,3-benzodioxol-5-ylmethyl)-6-phenylthieno[3,2-d]pyrimidin-4-amine

N-(1,3-benzodioxol-5-ylmethyl)-6-phenylthieno[3,2-d]pyrimidin-4-amine

C20H15N3O2S (361.0885)


   

methyl 2-((2-phenylimidazo[1,2-a]pyrimidin-3-yl)thio)benzoate

methyl 2-((2-phenylimidazo[1,2-a]pyrimidin-3-yl)thio)benzoate

C20H15N3O2S (361.0885)


   

Tryptophan, N-indol-3-ylacetyl- (6CI)

Tryptophan, N-indol-3-ylacetyl- (6CI)

C21H19N3O3 (361.1426)


   
   
   

Guanosine 5-monophosphate

Guanosine 5-monophosphate

C11H16N5O7P (361.0787)


   

2-acetoxy-1-methoxy-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridine|decarine acetate|O-acetyl-decarine|O-Acetyldecarin

2-acetoxy-1-methoxy-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridine|decarine acetate|O-acetyl-decarine|O-Acetyldecarin

C21H15NO5 (361.095)


   
   

N6-methyl-[3]adenylic acid|N6-Methyl-[3]adenylsaeure|N6-Methyladenosin-3-phosphat|N6-Methyladenylsaeure

N6-methyl-[3]adenylic acid|N6-Methyl-[3]adenylsaeure|N6-Methyladenosin-3-phosphat|N6-Methyladenylsaeure

C11H16N5O7P (361.0787)


   

sarcomejine B

sarcomejine B

C18H19NO7 (361.1161)


   
   
   

Polycarpamine A

Polycarpamine A

C15H23NO3S3 (361.084)


   

6-(3-(1H-pyrrole-2-carbonyloxy)-2-hydroxypropoxy)-3,4,5-trihydroxy-tetrahydro-2H-pyrane-2-carboxylic acid

6-(3-(1H-pyrrole-2-carbonyloxy)-2-hydroxypropoxy)-3,4,5-trihydroxy-tetrahydro-2H-pyrane-2-carboxylic acid

C14H19NO10 (361.1009)


   

2-(1-carboxyethyl)-5-hydroxy-7-phenyl-2H-benzo[de]isoquinoline-1,6-dione

2-(1-carboxyethyl)-5-hydroxy-7-phenyl-2H-benzo[de]isoquinoline-1,6-dione

C21H15NO5 (361.095)


   

2-Butyl-5-hydroxy-7-(4-hydroxyphenyl)-6H-benzo[de]isoquinoline-1,6(2H)-dione

2-Butyl-5-hydroxy-7-(4-hydroxyphenyl)-6H-benzo[de]isoquinoline-1,6(2H)-dione

C22H19NO4 (361.1314)


   

Me glycoside,N,2,4,6-tetra-Ac-alpha-D-Pyranose-3-Amino-3-deoxyglucose|Me glycoside,N,2,4,6-tetra-Ac-beta-D-Pyranose-3-Amino-3-deoxyglucose

Me glycoside,N,2,4,6-tetra-Ac-alpha-D-Pyranose-3-Amino-3-deoxyglucose|Me glycoside,N,2,4,6-tetra-Ac-beta-D-Pyranose-3-Amino-3-deoxyglucose

C15H23NO9 (361.1373)


   

3-deoxy-D-manno-2-octulopyranosonate 7-(2-aminoethyl phosphate)

3-deoxy-D-manno-2-octulopyranosonate 7-(2-aminoethyl phosphate)

C10H20NO11P (361.0774)


   
   

N6-Methyl-2adenylsaeure|N6-methyl-[2]adenylic acid|N6-Methyl-[2]adenylsaeure

N6-Methyl-2adenylsaeure|N6-methyl-[2]adenylic acid|N6-Methyl-[2]adenylsaeure

C11H16N5O7P (361.0787)


   

Me glycoside,2,3-dimesyl,N-Ac-4-Amino-4-deoxyarabinose

Me glycoside,2,3-dimesyl,N-Ac-4-Amino-4-deoxyarabinose

C10H19NO9S2 (361.0501)


   

2-Dimethylamino-4-oxo-6-(L-threo-1,2,3-trihydroxypropyl)-3,4-dihydropteridin-3-monophosphat

2-Dimethylamino-4-oxo-6-(L-threo-1,2,3-trihydroxypropyl)-3,4-dihydropteridin-3-monophosphat

C11H16N5O7P (361.0787)


   

7-Carbomethoxy-Evodiamine

7-Carbomethoxy-Evodiamine

C21H19N3O3 (361.1426)


   
   
   
   
   
   
   
   
   
   
   
   

Micinovo; Pravacilin; Rastomycin K; Ruticina

Micinovo; Pravacilin; Rastomycin K; Ruticina

C17H19N3O4S (361.1096)


   

bezafibrate

2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl-propanoic acid

C19H20ClNO4 (361.1081)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites CONFIDENCE standard compound; INTERNAL_ID 559; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4657; ORIGINAL_PRECURSOR_SCAN_NO 4655 CONFIDENCE standard compound; INTERNAL_ID 559; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4682; ORIGINAL_PRECURSOR_SCAN_NO 4681 CONFIDENCE standard compound; INTERNAL_ID 559; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4636; ORIGINAL_PRECURSOR_SCAN_NO 4635 CONFIDENCE standard compound; INTERNAL_ID 559; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4660; ORIGINAL_PRECURSOR_SCAN_NO 4659 CONFIDENCE standard compound; INTERNAL_ID 559; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4651; ORIGINAL_PRECURSOR_SCAN_NO 4650 CONFIDENCE standard compound; INTERNAL_ID 559; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8993; ORIGINAL_PRECURSOR_SCAN_NO 8991 CONFIDENCE standard compound; INTERNAL_ID 559; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9030; ORIGINAL_PRECURSOR_SCAN_NO 9028 CONFIDENCE standard compound; INTERNAL_ID 559; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9048; ORIGINAL_PRECURSOR_SCAN_NO 9046 CONFIDENCE standard compound; INTERNAL_ID 559; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9079; ORIGINAL_PRECURSOR_SCAN_NO 9078 CONFIDENCE standard compound; INTERNAL_ID 559; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9087; ORIGINAL_PRECURSOR_SCAN_NO 9085 CONFIDENCE standard compound; INTERNAL_ID 559; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9094; ORIGINAL_PRECURSOR_SCAN_NO 9093 CONFIDENCE standard compound; INTERNAL_ID 2341 CONFIDENCE standard compound; INTERNAL_ID 8548 CONFIDENCE standard compound; INTERNAL_ID 4069 CONFIDENCE standard compound; EAWAG_UCHEM_ID 209 Bezafibrate is an agonist of PPAR, with EC50s of 50 μM, 60 μM, 20 μM for human PPARα, PPARγ and PPARδ, and 90 μM, 55 μM, 110 μM for murine PPARα, PPARγ and PPARδ, respectively; Bezafibrate is used as an hypolipidemic agent.

   

Indole-3-acetyl-L-tryptophan

Indole-3-acetyl-L-tryptophan

C21H19N3O3 (361.1426)


Annotation level-1

   

N4-Anisoyl-2-deoxycytidine

N4-Anisoyl-2-deoxycytidine

C17H19N3O6 (361.1274)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.797 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.800 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.794

   

Varenicline Tartrate

Varenicline Tartrate

C17H19N3O6 (361.1274)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists D000077444 - Smoking Cessation Agents Varenicline (CP 526555) is an orally active partial agonist of α4β2 nicotinic acetylcholine receptor (α4β2 nAChR, IC50 = 250 nM), which is the principal mediator of nicotine dependence. Varenicline is also a partial agonist of α6β2 nAChR and a full agonist of α6β2 nAChR. Varenicline blocks the direct agonist effects of nicotine on nAChR while stimulates nAChR in a more moderate way, being widely used as an aid of smoking cessation[1][2][3][4][5]. Varenicline (CP 526555) is an orally active partial agonist of α4β2 nicotinic acetylcholine receptor (α4β2 nAChR, IC50 = 250 nM), which is the principal mediator of nicotine dependence. Varenicline is also a partial agonist of α6β2 nAChR and a full agonist of α6β2 nAChR. Varenicline blocks the direct agonist effects of nicotine on nAChR while stimulates nAChR in a more moderate way, being widely used as an aid of smoking cessation[1][2][3][4][5].

   

Ofloxacin (Floxin)

Ofloxacin (Floxin)

C18H20FN3O4 (361.1438)


   

Levofloxacin

Levofloxacin (Levaquin)

C18H20FN3O4 (361.1438)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

fenoxaprop-P-ethyl

fenoxaprop-P-ethyl

C18H16ClNO5 (361.0717)


   
   
   

5-HYDROXYOMEPRAZOLE

5-HYDROXY OMEPRAZOLE

C17H19N3O4S (361.1096)


   

Chloroaustralasine A

Chloroaustralasine A

C20H24ClNO3 (361.1445)


   

Isochloroaustralasine A

Isochloroaustralasine A

C20H24ClNO3 (361.1445)


   

Anabasamine

Anabasamine

C16H22Cl3N3 (361.0879)


Origin: Plant; SubCategory_DNP: Alkaloids derived from lysine, Quinolizidine alkaloids

   

1,N2-4-Oxo-2-hexenal-deoxyguanosine

1,N2-4-Oxo-2-hexenal-deoxyguanosine

C16H19N5O5 (361.1386)


   

Asp Gly Gly Asn

(2S)-2-(2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}acetamido)-3-carbamoylpropanoic acid

C12H19N5O8 (361.1234)


   

Asp Gly Asn Gly

(3S)-3-amino-3-[({[(1S)-2-carbamoyl-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C12H19N5O8 (361.1234)


   

Asp Asn Gly Gly

(3S)-3-amino-3-{[(1S)-2-carbamoyl-1-({[(carboxymethyl)carbamoyl]methyl}carbamoyl)ethyl]carbamoyl}propanoic acid

C12H19N5O8 (361.1234)


   

Gly Asp Gly Asn

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]acetamido}-3-carbamoylpropanoic acid

C12H19N5O8 (361.1234)


   

Gly Asp Asn Gly

(3S)-3-(2-aminoacetamido)-3-{[(1S)-2-carbamoyl-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}propanoic acid

C12H19N5O8 (361.1234)


   

Gly Gly Asp Asn

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-carboxypropanamido]-3-carbamoylpropanoic acid

C12H19N5O8 (361.1234)


   

Gly Gly Asn Asp

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-carbamoylpropanamido]butanedioic acid

C12H19N5O8 (361.1234)


   

Gly Asn Asp Gly

(3S)-3-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C12H19N5O8 (361.1234)


   

Gly Asn Gly Asp

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]acetamido}butanedioic acid

C12H19N5O8 (361.1234)


   

N-Acetylnorfloxacin

7-(4-acetylpiperazin-1-yl)-1-ethyl-6-fluoro-4-oxoquinoline-3-carboxylic acid

C18H20FN3O4 (361.1438)


   

Omeprazole sulfone

Omeprazole sulfone

C17H19N3O4S (361.1096)


   
   
   
   
   
   
   
   

Asn Asp Gly Gly

(3S)-3-[(2S)-2-amino-3-carbamoylpropanamido]-3-({[(carboxymethyl)carbamoyl]methyl}carbamoyl)propanoic acid

C12H19N5O8 (361.1234)


   

Asn Gly Asp Gly

(3S)-3-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-[(carboxymethyl)carbamoyl]propanoic acid

C12H19N5O8 (361.1234)


   

Asn Gly Gly Asp

(2S)-2-(2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}acetamido)butanedioic acid

C12H19N5O8 (361.1234)


   
   
   
   
   
   
   
   
   
   
   

metampicillin

metampicillin

C17H19N3O4S (361.1096)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum A penicillin compound having a 6beta-(2R)-2-(methylideneamino)-2-phenylacetamido side-group. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

OU749

N-[5-[(4-methoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]-benzenesulfonamide

C16H15N3O3S2 (361.0555)


   

Chelirubine

Chelirubine

C21H15NO5 (361.095)


   

3-Hydroxyomeprazole

{4-methoxy-2-[(6-methoxy-1H-1,3-benzodiazole-2-sulfinyl)methyl]-5-methylpyridin-3-yl}methanol

C17H19N3O4S (361.1096)


   

Avenanthramide A2

(2E)-N-[2-(dihydroxymethyl)-4-hydroxy-5-methoxyphenyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide

C18H19NO7 (361.1161)


   

De-O-methylsimmondsin

2-[(1E)-2,4-dihydroxy-3-methoxy-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexylidene]acetonitrile

C15H23NO9 (361.1373)


   

Ethylendiamine-N,N-disuccinic acid

Ethylendiamine-N,N-disuccinic acid

C10H16N2Na3O8- (361.06)


   

3-[[2-(4-benzylphenoxy)acetyl]amino]benzoic acid

3-[[2-(4-benzylphenoxy)acetyl]amino]benzoic acid

C22H19NO4 (361.1314)


   

dibenzyl 5-aminobenzene-1,3-dicarboxylate

dibenzyl 5-aminobenzene-1,3-dicarboxylate

C22H19NO4 (361.1314)


   

Fostedil

2-[4-(DIETHOXYPHOSPHORYLMETHYL)PHENYL]BENZOTHIAZOLE

C18H20NO3PS (361.0901)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

1-cyclopropyl-6-fluoro-8-hydroxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid

1-cyclopropyl-6-fluoro-8-hydroxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid

C18H20FN3O4 (361.1438)


   
   

(2E)-2-[3-chloro-6-(4-methylpiperazin-1-yl)dibenzo[1,2-[7]annulen-11-ylidene]acetonitrile

(2E)-2-[3-chloro-6-(4-methylpiperazin-1-yl)dibenzo[1,2-[7]annulen-11-ylidene]acetonitrile

C22H20ClN3 (361.1346)


   

TRANS-3 4-BENZYLOXY-TRANS-B-NITROSTYREN&

TRANS-3 4-BENZYLOXY-TRANS-B-NITROSTYREN&

C22H19NO4 (361.1314)


   

Fmoc-(S)-2-Amino-4,4-difluorobutyric acid

Fmoc-(S)-2-Amino-4,4-difluorobutyric acid

C19H17F2NO4 (361.1126)


   

benzyl 3-(3-aminoazetidin-1-yl)piperidine-1-carboxylate,dihydrochloride

benzyl 3-(3-aminoazetidin-1-yl)piperidine-1-carboxylate,dihydrochloride

C16H25Cl2N3O2 (361.1324)


   

3-(3-AMINOMETHYL-AZETIDIN-1-YL)-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER-2HCl

3-(3-AMINOMETHYL-AZETIDIN-1-YL)-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER-2HCl

C16H25Cl2N3O2 (361.1324)


   

ETHYL 2-(CHLOROMETHYL)-4-PHENYLQUINOLINE-3-CARBOXYLATE HYDROCHLORIDE

ETHYL 2-(CHLOROMETHYL)-4-PHENYLQUINOLINE-3-CARBOXYLATE HYDROCHLORIDE

C19H17Cl2NO2 (361.0636)


   

(1-CBZ-PIPERIDIN-4-YL-AZETIDIN-3-YL)-AMINE-2HCl

(1-CBZ-PIPERIDIN-4-YL-AZETIDIN-3-YL)-AMINE-2HCl

C16H25Cl2N3O2 (361.1324)


   

rel-(1R,3S,5S)-8-Methyl-8-azabicyclo[3,2,1]oct-6-en-yl-2-hydroxy-2,2-dithiophen-2-yl acetate

rel-(1R,3S,5S)-8-Methyl-8-azabicyclo[3,2,1]oct-6-en-yl-2-hydroxy-2,2-dithiophen-2-yl acetate

C18H19NO3S2 (361.0806)


   

4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl acetate

4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl acetate

C17H13ClFN3O3 (361.0629)


   

N4-Bz-2-OMe-rC

N4-Bz-2-OMe-rC

C17H19N3O6 (361.1274)


N4-Benzoyl-2’-O-methylcytidine is a cytidine analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities[1].

   

4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl acetate

4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl acetate

C17H13ClFN3O3 (361.0629)


   

Clemizole hydrochloride

Clemizole hydrochloride

C19H21Cl2N3 (361.1112)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Clemizole hydrochloride is an H1 histamine receptor antagonist, is found to substantially inhibit HCV replication. Clemizole hydrochloride is an inhibitor of TRPC5 channel. The IC50 of Clemizole hydrochloride for RNA binding by NS4B is 24 nM, whereas its EC50 for viral replication is 8 μM.

   

(S)-4-(1-HYDROXY-2-(ISOPROPYLAMINO)ETHYL)BENZENE-1,2-DIOL (2R,3R)-2,3-DIHYDROXYSUCCINATE

(S)-4-(1-HYDROXY-2-(ISOPROPYLAMINO)ETHYL)BENZENE-1,2-DIOL (2R,3R)-2,3-DIHYDROXYSUCCINATE

C15H23NO9 (361.1373)


   

1-CYCLOPROPYL-6-FLUORO-8-METHOXY-4-OXO-7-(PIPERAZIN-1-YL)-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID

1-CYCLOPROPYL-6-FLUORO-8-METHOXY-4-OXO-7-(PIPERAZIN-1-YL)-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID

C18H20FN3O4 (361.1438)


   
   

(S)-ALLYL 2-AMINO-4-(METHYLTHIO)BUTANOATE 4-METHYLBENZENESULFONATE

(S)-ALLYL 2-AMINO-4-(METHYLTHIO)BUTANOATE 4-METHYLBENZENESULFONATE

C15H23NO5S2 (361.1018)


   

5-(AMINOMETHYL)-3,6-DIHYDROXY-3H-SPIRO[ISOBENZOFURAN-1,9-XANTHEN]-3-ONE HYDROCHLORIDE

5-(AMINOMETHYL)-3,6-DIHYDROXY-3H-SPIRO[ISOBENZOFURAN-1,9-XANTHEN]-3-ONE HYDROCHLORIDE

C21H15NO5 (361.095)


   

ethyl 2,3-dihydro-2-(3-hydroxy-2-quinolyl)-1,3-dioxo-1H-indene-5-carboxylate

ethyl 2,3-dihydro-2-(3-hydroxy-2-quinolyl)-1,3-dioxo-1H-indene-5-carboxylate

C21H15NO5 (361.095)


   

Midazolam hydrochloride

Midazolam hydrochloride

C18H14Cl2FN3 (361.0549)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

3-PHENYL-6-(3,4,5-TRIMETHOXY-PHENYL)-PYRAZOLO[1,5-A]PYRIMIDINE

3-PHENYL-6-(3,4,5-TRIMETHOXY-PHENYL)-PYRAZOLO[1,5-A]PYRIMIDINE

C21H19N3O3 (361.1426)


   

[4-[cyclopropyl-[(4-methoxyphenyl)methyl]sulfamoyl]phenyl]boronic acid

[4-[cyclopropyl-[(4-methoxyphenyl)methyl]sulfamoyl]phenyl]boronic acid

C17H20BNO5S (361.1155)


   

3-[Cyclopropyl(4-methoxybenzyl)sulfamoyl]benzeneboronic acid

3-[Cyclopropyl(4-methoxybenzyl)sulfamoyl]benzeneboronic acid

C17H20BNO5S (361.1155)


   

1-(4-Methylamino-2-piperidin-3-yl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl)-ethanone diHCl

1-(4-Methylamino-2-piperidin-3-yl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl)-ethanone diHCl

C15H25Cl2N5O (361.1436)


   

Sparsomysin

SPARSOMYCIN

C13H19N3O5S2 (361.0766)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000970 - Antineoplastic Agents

   

4,4-diphenylbutan-2-yl-ethyl-dimethylazanium,bromide

4,4-diphenylbutan-2-yl-ethyl-dimethylazanium,bromide

C20H28BrN (361.1405)


   

[5-[7-(3-Chloropropoxy)quinazolin-4-ylamino]pyrazol-3-yl]acetic acid

[5-[7-(3-Chloropropoxy)quinazolin-4-ylamino]pyrazol-3-yl]acetic acid

C16H16ClN5O3 (361.0942)


   

6,7-dimethoxy-2-(4-methylphenyl)sulfonyl-1,3-dihydroisoquinolin-4-one

6,7-dimethoxy-2-(4-methylphenyl)sulfonyl-1,3-dihydroisoquinolin-4-one

C18H19NO5S (361.0984)


   

(E)-8-Hydroxy-2-[2-(3,4,5-trihydroxyphenyl)ethenyl]-7-quinolinecarboxylic acid sodium salt

(E)-8-Hydroxy-2-[2-(3,4,5-trihydroxyphenyl)ethenyl]-7-quinolinecarboxylic acid sodium salt

C18H12NNaO6 (361.0562)


   

TAK-242

Resatorvid

C15H17ClFNO4S (361.0551)


C308 - Immunotherapeutic Agent

   

(-)-Isoproterenol tartrate

(-)-Isoproterenol tartrate

C15H23NO9 (361.1373)


   

2H-Pyrrol-2-one, 4-acetyl-1-(4-chloro-3-ethylphenyl)-5-cyclohexyl-1,5-dihydro-3-hydroxy-

2H-Pyrrol-2-one, 4-acetyl-1-(4-chloro-3-ethylphenyl)-5-cyclohexyl-1,5-dihydro-3-hydroxy-

C20H24ClNO3 (361.1445)


   

N-BOC-N,N-BIS{2-[(METHANESULFONYL)OXY]ETHYL}AMINE

N-BOC-N,N-BIS{2-[(METHANESULFONYL)OXY]ETHYL}AMINE

C11H23NO8S2 (361.0865)


   

BULBOCAPNINE HYDROCHLORIDE

BULBOCAPNINE HYDROCHLORIDE

C19H20ClNO4 (361.1081)


   

[4-(2,4-difluorophenyl)-2-(morpholine-4-carbonyl)phenyl] acetate

[4-(2,4-difluorophenyl)-2-(morpholine-4-carbonyl)phenyl] acetate

C19H17F2NO4 (361.1126)


   

1-(4-METHOXY-BENZYL)-1H-BENZOIMIDAZOL-5-YLAMINE TRIHYDROCHLORIDE

1-(4-METHOXY-BENZYL)-1H-BENZOIMIDAZOL-5-YLAMINE TRIHYDROCHLORIDE

C15H18Cl3N3O (361.0515)


   

2-(4-FORMYL-2-METHOXYPHENOXY)ACETIC ACID, N-(2-BIPHENYLYL)AMIDE

2-(4-FORMYL-2-METHOXYPHENOXY)ACETIC ACID, N-(2-BIPHENYLYL)AMIDE

C22H19NO4 (361.1314)


   

Chlorodipiperidinocarbenium Hexafluorophosphate

Chlorodipiperidinocarbenium Hexafluorophosphate

C11H21ClF6N2P (361.1035)


   

2-ETHOXY-5-[(4-METHYL-PIPERAZINE-1-CARBONYL)-AMINO]-BENZENESULFONYL CHLORIDE

2-ETHOXY-5-[(4-METHYL-PIPERAZINE-1-CARBONYL)-AMINO]-BENZENESULFONYL CHLORIDE

C14H20ClN3O4S (361.0863)


   

FENOXAPROP-ETHYL

FENOXAPROP-ETHYL

C18H16ClNO5 (361.0717)


D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

   

1-Cyclohexene-1-carboxylic acid, 6-[[(2-chloro-4-fluorophenyl)amino]sulfonyl]-, ethyl ester, (6S)-

1-Cyclohexene-1-carboxylic acid, 6-[[(2-chloro-4-fluorophenyl)amino]sulfonyl]-, ethyl ester, (6S)-

C15H17ClFNO4S (361.0551)


   

ethyl 2-(2-(2-(4-chlorophenoxy)phenyl)-N-Methylacetamido)acetate

ethyl 2-(2-(2-(4-chlorophenoxy)phenyl)-N-Methylacetamido)acetate

C19H20ClNO4 (361.1081)


   

1-(3-Fluorophenyl)-6-methyl-3-(2-quinolinylmethoxy)-4(1H)-pyridazinone

1-(3-Fluorophenyl)-6-methyl-3-(2-quinolinylmethoxy)-4(1H)-pyridazinone

C21H16FN3O2 (361.1226)


   

Levofloxacin Ethyl Ester

Levofloxacin Ethyl Ester

C18H20FN3O4 (361.1438)


   

(±)-(isopropyl)(beta,3,4-trihydroxyphenethyl)ammonium [R-(R*,R*)]-hydrogen tartrate

(±)-(isopropyl)(beta,3,4-trihydroxyphenethyl)ammonium [R-(R*,R*)]-hydrogen tartrate

C11H17NO3.C4H6O6 (361.1373)


   

Disperse Red 146

Disperse Red 146

C21H15NO5 (361.095)


   

5-[(4-chloro-2-nitrophenyl)azo]-1-ethyl-1,2-dihydro-6-hydroxy-4-methyl-2-oxonicotinonitrile

5-[(4-chloro-2-nitrophenyl)azo]-1-ethyl-1,2-dihydro-6-hydroxy-4-methyl-2-oxonicotinonitrile

C15H12ClN5O4 (361.0578)


   

ETHYL (2S)-(+)-2-(4-(6-CHLOROBENZOXAZOL&

ETHYL (2S)-(+)-2-(4-(6-CHLOROBENZOXAZOL&

C18H16ClNO5 (361.0717)


   

Methyl 2-(2-(benzyloxycarbonylamino)propan-2-yl)-5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxylate

Methyl 2-(2-(benzyloxycarbonylamino)propan-2-yl)-5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxylate

C17H19N3O6 (361.1274)


   

Methyl 2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]-6-[(1E)-N-methoxyetha nimidoyl]benzoate

Methyl 2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]-6-[(1E)-N-methoxyetha nimidoyl]benzoate

C17H19N3O6 (361.1274)


   

4-Chloro-2,5-bis(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzonitrile

4-Chloro-2,5-bis(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzonitrile

C17H22B2ClNO4 (361.1423)


   

TRANS-3 5-BENZYLOXY-TRANS-B-NITROSTYREN&

TRANS-3 5-BENZYLOXY-TRANS-B-NITROSTYREN&

C22H19NO4 (361.1314)


   

1-(4-Fluorophenyl)-6-methyl-3-(2-quinolinylmethoxy)-4(1H)-pyridazinone

1-(4-Fluorophenyl)-6-methyl-3-(2-quinolinylmethoxy)-4(1H)-pyridazinone

C21H16FN3O2 (361.1226)


   

2-(5H-[1,2,4]triazino[5,6-b]indol-3-ylsulfanylmethyl)isoindole-1,3-dione

2-(5H-[1,2,4]triazino[5,6-b]indol-3-ylsulfanylmethyl)isoindole-1,3-dione

C18H11N5O2S (361.0633)


   

A-TOSYL-(3,4,5-TRIMETHOXYLBENZYL)ISOCYANIDE

A-TOSYL-(3,4,5-TRIMETHOXYLBENZYL)ISOCYANIDE

C18H19NO5S (361.0984)


   

Disperse Yellow 211

Disperse Yellow 211

C15H12ClN5O4 (361.0578)


   

Polmacoxib

Polmacoxib

C18H16FNO4S (361.0784)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AH - Coxibs C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C80509 - COX-2 Inhibitor C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor

   

Zimlovisertib

Zimlovisertib

C18H20FN3O4 (361.1438)


C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent > C184956 - IRAK4 Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C274 - Antineoplastic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

N6-Methyladenosine-5-monophosphate

N6-Methyladenosine-5-monophosphate

C11H16N5O7P (361.0787)


   

2-Methyladenosine 5-(dihydrogen phosphate)

2-Methyladenosine 5-(dihydrogen phosphate)

C11H16N5O7P (361.0787)


   

2-O-methyladenosine 5-monophosphate

2-O-methyladenosine 5-monophosphate

C11H16N5O7P (361.0787)


   

4-[[5-Ethyl-3-(4-methoxybenzoyl)thiophen-2-yl]amino]-4-oxobutanoic acid

4-[[5-Ethyl-3-(4-methoxybenzoyl)thiophen-2-yl]amino]-4-oxobutanoic acid

C18H19NO5S (361.0984)


   

6-O-Methyl guanosine-5-monophosphate

6-O-Methyl guanosine-5-monophosphate

C11H16N5O7P (361.0787)


   

4-[3-Methyl-5-(4-methylphenyl)-6-oxo-2,4-dihydropyrrolo[3,4-c]pyrazol-4-yl]benzoic acid methyl ester

4-[3-Methyl-5-(4-methylphenyl)-6-oxo-2,4-dihydropyrrolo[3,4-c]pyrazol-4-yl]benzoic acid methyl ester

C21H19N3O3 (361.1426)


   

Dimethyl 2-{4-[(3-chlorobenzoyl)amino]phenyl}malonate

Dimethyl 2-{4-[(3-chlorobenzoyl)amino]phenyl}malonate

C18H16ClNO5 (361.0717)


   

N-[(4-chlorophenyl)-(2-methyl-1H-indol-3-yl)methyl]-4-methyl-2-pyridinamine

N-[(4-chlorophenyl)-(2-methyl-1H-indol-3-yl)methyl]-4-methyl-2-pyridinamine

C22H20ClN3 (361.1346)


   

3-(1-Benzotriazolylmethyl)-6-(2-phenylethyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

3-(1-Benzotriazolylmethyl)-6-(2-phenylethyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole

C18H15N7S (361.111)


   

2-[[3-(4-Fluorophenyl)-7-triazolo[4,5-d]pyrimidinyl]thio]butanoic acid ethyl ester

2-[[3-(4-Fluorophenyl)-7-triazolo[4,5-d]pyrimidinyl]thio]butanoic acid ethyl ester

C16H16FN5O2S (361.1009)


   

8-Methyladenosine 5-monophosphate

8-Methyladenosine 5-monophosphate

C11H16N5O7P (361.0787)


   

N-hydroxy-4-aminobiphenyl O-glucuronide

N-hydroxy-4-aminobiphenyl O-glucuronide

C18H19NO7 (361.1161)


   

5-PyriMidinecarboxaMide, N-(5-fluoro-3-Methyl-1H-indol-1-yl)-4-Methyl-2-(2-pyridinyl)-

5-PyriMidinecarboxaMide, N-(5-fluoro-3-Methyl-1H-indol-1-yl)-4-Methyl-2-(2-pyridinyl)-

C20H16FN5O (361.1339)


   

5-amino-2-{4-[(4-aminophenyl)sulfanyl]phenyl}-1H-isoindole-1,3(2H)-dione

5-amino-2-{4-[(4-aminophenyl)sulfanyl]phenyl}-1H-isoindole-1,3(2H)-dione

C20H15N3O2S (361.0885)


   

4-{4-[(5-Hydroxy-2-Methylphenyl)amino]quinolin-7-Yl}-1,3-Thiazole-2-Carbaldehyde

4-{4-[(5-Hydroxy-2-Methylphenyl)amino]quinolin-7-Yl}-1,3-Thiazole-2-Carbaldehyde

C20H15N3O2S (361.0885)


   

N(1)-methyladenosine 5-monophosphate

N(1)-methyladenosine 5-monophosphate

C11H16N5O7P (361.0787)


   

(2s)-3-[(R)-[(1s)-1-Amino-3-Phenylpropyl](Hydroxy)phosphoryl]-2-Benzylpropanoic Acid

(2s)-3-[(R)-[(1s)-1-Amino-3-Phenylpropyl](Hydroxy)phosphoryl]-2-Benzylpropanoic Acid

C19H24NO4P (361.1443)


   

(6Z)-6-{[(1Z)-1-{[(1R)-1-Carboxy-2-methyl-2-propen-1-yl]imino}-1-hydroxy-3-sulfanyl-2-propanyl]imino}-6-hydroxynorleucine

(6Z)-6-{[(1Z)-1-{[(1R)-1-Carboxy-2-methyl-2-propen-1-yl]imino}-1-hydroxy-3-sulfanyl-2-propanyl]imino}-6-hydroxynorleucine

C14H23N3O6S (361.1307)


   

N-(1H-indol-3-ylacetyl)tryptophan

N-(1H-indol-3-ylacetyl)tryptophan

C21H19N3O3 (361.1426)


   

5-(tert-butylsulfamoyl)-2-methyl-N-(5-methylpyridin-2-yl)benzamide

5-(tert-butylsulfamoyl)-2-methyl-N-(5-methylpyridin-2-yl)benzamide

C18H23N3O3S (361.146)


   

N-p-Anisoyldeoxycytidine

N-p-Anisoyldeoxycytidine

C17H19N3O6 (361.1274)


   

(2S)-3-(1H-indol-3-yl)-2-[[2-(1H-indol-3-yl)acetyl]amino]propanoic acid

(2S)-3-(1H-indol-3-yl)-2-[[2-(1H-indol-3-yl)acetyl]amino]propanoic acid

C21H19N3O3 (361.1426)


   
   

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-2-methyl-N-sulfooxypropanimidothioate

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-2-methyl-N-sulfooxypropanimidothioate

C10H19NO9S2 (361.0501)


   

6-(1,3-benzodioxol-5-yl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine

6-(1,3-benzodioxol-5-yl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine

C20H15N3O2S (361.0885)


   

1-Azabicyclo[2.2.2]octan-3-yl-bis(3-chlorophenyl)methanol

1-Azabicyclo[2.2.2]octan-3-yl-bis(3-chlorophenyl)methanol

C20H21Cl2NO (361.1)


   

3,4-dimethoxy-N-[[[oxo(2-pyrazinyl)methyl]hydrazo]-sulfanylidenemethyl]benzamide

3,4-dimethoxy-N-[[[oxo(2-pyrazinyl)methyl]hydrazo]-sulfanylidenemethyl]benzamide

C15H15N5O4S (361.0845)


   

1-Amino-5-(4-morpholinyl)-6,7,8,9-tetrahydrothieno[2,3-c]isoquinoline-2-carboxylic acid ethyl ester

1-Amino-5-(4-morpholinyl)-6,7,8,9-tetrahydrothieno[2,3-c]isoquinoline-2-carboxylic acid ethyl ester

C18H23N3O3S (361.146)


   

1-(3,5-Dimethylphenyl)-3-[5-(dimethylsulfamoyl)-2-methylphenyl]urea

1-(3,5-Dimethylphenyl)-3-[5-(dimethylsulfamoyl)-2-methylphenyl]urea

C18H23N3O3S (361.146)


   

(1,2-Dimethyl-3-indolyl)-diphenyl-sulfanylidenephosphorane

(1,2-Dimethyl-3-indolyl)-diphenyl-sulfanylidenephosphorane

C22H20NPS (361.1054)


   

1-S-[(1Z)-2-methyl-N-(sulfooxy)propanimidoyl]-1-thio-beta-D-glucopyranose

1-S-[(1Z)-2-methyl-N-(sulfooxy)propanimidoyl]-1-thio-beta-D-glucopyranose

C10H19NO9S2 (361.0501)


   
   
   

N-[2-(2-ethyl-5-tetrazolyl)phenyl]-3-(1-tetrazolyl)benzamide

N-[2-(2-ethyl-5-tetrazolyl)phenyl]-3-(1-tetrazolyl)benzamide

C17H15N9O (361.14)


   

N-(4-methoxyphenyl)-5-[2-(trifluoromethyl)phenyl]-2-furancarboxamide

N-(4-methoxyphenyl)-5-[2-(trifluoromethyl)phenyl]-2-furancarboxamide

C19H14F3NO3 (361.0926)


   

2,4-Dichloro-6-[1-(4-morpholinyl)-3-phenylprop-2-ynyl]phenol

2,4-Dichloro-6-[1-(4-morpholinyl)-3-phenylprop-2-ynyl]phenol

C19H17Cl2NO2 (361.0636)


   

1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-[(2-pyridinylthio)methyl]-4-triazolecarboxylic acid propan-2-yl ester

1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-[(2-pyridinylthio)methyl]-4-triazolecarboxylic acid propan-2-yl ester

C14H15N7O3S (361.0957)


   

2-(2-methyl-1-benzimidazolyl)acetic acid [2-(2-methyl-1H-indol-3-yl)-2-oxoethyl] ester

2-(2-methyl-1-benzimidazolyl)acetic acid [2-(2-methyl-1H-indol-3-yl)-2-oxoethyl] ester

C21H19N3O3 (361.1426)


   

1-(4-Chlorophenyl)-2-[[4-ethyl-5-(2-methyl-3-furanyl)-1,2,4-triazol-3-yl]thio]ethanone

1-(4-Chlorophenyl)-2-[[4-ethyl-5-(2-methyl-3-furanyl)-1,2,4-triazol-3-yl]thio]ethanone

C17H16ClN3O2S (361.0652)


   

(4Z)-2-(4-methoxyphenyl)-4-[(1,2,4-triazol-4-ylamino)methylidene]isoquinoline-1,3-dione

(4Z)-2-(4-methoxyphenyl)-4-[(1,2,4-triazol-4-ylamino)methylidene]isoquinoline-1,3-dione

C19H15N5O3 (361.1175)


   

6-(3-methoxyphenyl)-N-[(4-methyl-2-thiophenyl)methyl]-4-quinazolinamine

6-(3-methoxyphenyl)-N-[(4-methyl-2-thiophenyl)methyl]-4-quinazolinamine

C21H19N3OS (361.1249)


   

2-(4-Fluoro-3-methylphenyl)sulfonyl-5-(2-methoxyphenyl)-3-pyrazolamine

2-(4-Fluoro-3-methylphenyl)sulfonyl-5-(2-methoxyphenyl)-3-pyrazolamine

C17H16FN3O3S (361.0896)


   

4-chloro-N-{[2-(3-phenylpropanoyl)hydrazino]carbothioyl}benzamide

4-chloro-N-{[2-(3-phenylpropanoyl)hydrazino]carbothioyl}benzamide

C17H16ClN3O2S (361.0652)


   

4-[(2-Methylanilino)methylidene]-2-(2-thiazolyl)isoquinoline-1,3-dione

4-[(2-Methylanilino)methylidene]-2-(2-thiazolyl)isoquinoline-1,3-dione

C20H15N3O2S (361.0885)


   

(E)-3-(4-methoxyphenyl)-N-[(thiophene-2-carbonylamino)carbamothioyl]prop-2-enamide

(E)-3-(4-methoxyphenyl)-N-[(thiophene-2-carbonylamino)carbamothioyl]prop-2-enamide

C16H15N3O3S2 (361.0555)


   

5-[4-(diethylamino)-2-methoxybenzylidene]-1-ethyl-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione

5-[4-(diethylamino)-2-methoxybenzylidene]-1-ethyl-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione

C18H23N3O3S (361.146)


   

methyl (2-chloro-5-{(1Z)-N-[(6-methylpyridin-2-yl)methoxy]ethanimidoyl}benzyl)carbamate

methyl (2-chloro-5-{(1Z)-N-[(6-methylpyridin-2-yl)methoxy]ethanimidoyl}benzyl)carbamate

C18H20ClN3O3 (361.1193)


   

4-[[4-(4-Methoxyphenyl)-2-thiazolyl]amino]benzenesulfonamide

4-[[4-(4-Methoxyphenyl)-2-thiazolyl]amino]benzenesulfonamide

C16H15N3O3S2 (361.0555)


   

N-[2-(2-ethyl-5-tetrazolyl)phenyl]-4-(1-tetrazolyl)benzamide

N-[2-(2-ethyl-5-tetrazolyl)phenyl]-4-(1-tetrazolyl)benzamide

C17H15N9O (361.14)


   

1-(Benzenesulfonyl)-3-(4-methoxyphenyl)-5-(methylthio)-1,2,4-triazole

1-(Benzenesulfonyl)-3-(4-methoxyphenyl)-5-(methylthio)-1,2,4-triazole

C16H15N3O3S2 (361.0555)


   

2-Cyano-3-(4,5-dimethoxy-2-nitro-phenyl)-N-(tetrahydro-furan-2-ylmethyl)-acrylamide

2-Cyano-3-(4,5-dimethoxy-2-nitro-phenyl)-N-(tetrahydro-furan-2-ylmethyl)-acrylamide

C17H19N3O6 (361.1274)


   

2-[methyl-(2,4,6-trimethylphenyl)sulfonylamino]-N-(2-pyridinylmethyl)acetamide

2-[methyl-(2,4,6-trimethylphenyl)sulfonylamino]-N-(2-pyridinylmethyl)acetamide

C18H23N3O3S (361.146)


   

(5E)-5-(1-ethylquinolin-2-ylidene)-3-methyl-1-phenyl-2-sulfanylideneimidazolidin-4-one

(5E)-5-(1-ethylquinolin-2-ylidene)-3-methyl-1-phenyl-2-sulfanylideneimidazolidin-4-one

C21H19N3OS (361.1249)


   

N-(3,4-dimethoxyphenyl)-2-[(4-oxo-4,5,6,7-tetrahydro-3H-cyclopenta[d]pyrimidin-2-yl)thio]acetamide

N-(3,4-dimethoxyphenyl)-2-[(4-oxo-4,5,6,7-tetrahydro-3H-cyclopenta[d]pyrimidin-2-yl)thio]acetamide

C17H19N3O4S (361.1096)


   

proatranorin II

proatranorin II

C18H17O8- (361.0923)


   

3-Methylbutyl (1S,5R,7R)-4-oxo-3-(thiophen-2-ylmethyl)-10-oxa-3-azatricyclo[5.2.1.01,5]dec-8-ene-6-carboxylate

3-Methylbutyl (1S,5R,7R)-4-oxo-3-(thiophen-2-ylmethyl)-10-oxa-3-azatricyclo[5.2.1.01,5]dec-8-ene-6-carboxylate

C19H23NO4S (361.1348)


   

2-[[(6-methyl-5-oxo-2H-1,2,4-triazin-3-yl)thio]methyl]-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-4-one

2-[[(6-methyl-5-oxo-2H-1,2,4-triazin-3-yl)thio]methyl]-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-4-one

C15H15N5O2S2 (361.0667)


   

2-cyclopropyl-N-[(1E)-1-(2,4-dihydroxyphenyl)ethylidene]quinoline-4-carbohydrazide

2-cyclopropyl-N-[(1E)-1-(2,4-dihydroxyphenyl)ethylidene]quinoline-4-carbohydrazide

C21H19N3O3 (361.1426)


   

4-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-5-imino-1-pentyl-2H-pyrrol-3-ol

4-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-5-imino-1-pentyl-2H-pyrrol-3-ol

C18H20ClN3OS (361.1016)


   
   
   
   
   
   
   

N-[3-(2-chloro-10-phenothiazinyl)propyl]butane-1,4-diamine

N-[3-(2-chloro-10-phenothiazinyl)propyl]butane-1,4-diamine

C19H24ClN3S (361.1379)


   

2-[(2S,5S,6S)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]acetic acid methyl ester

2-[(2S,5S,6S)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]acetic acid methyl ester

C15H20FNO6S (361.0995)


   

methyl 2-[(2R,5R,6S)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)oxan-2-yl]acetate

methyl 2-[(2R,5R,6S)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)oxan-2-yl]acetate

C15H20FNO6S (361.0995)


   

methyl 2-[(2R,5S,6S)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)oxan-2-yl]acetate

methyl 2-[(2R,5S,6S)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)oxan-2-yl]acetate

C15H20FNO6S (361.0995)


   

2-[(2S,5R,6S)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]acetic acid methyl ester

2-[(2S,5R,6S)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]acetic acid methyl ester

C15H20FNO6S (361.0995)


   

methyl 2-[(2S,5S,6R)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)oxan-2-yl]acetate

methyl 2-[(2S,5S,6R)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)oxan-2-yl]acetate

C15H20FNO6S (361.0995)


   

methyl (1R,9S,10S,11S)-10-(hydroxymethyl)-6-oxo-12-(1,3-thiazol-2-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate

methyl (1R,9S,10S,11S)-10-(hydroxymethyl)-6-oxo-12-(1,3-thiazol-2-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate

C17H19N3O4S (361.1096)


   

methyl (1S,9R,10R,11R)-10-(hydroxymethyl)-6-oxo-12-(1,3-thiazol-2-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate

methyl (1S,9R,10R,11R)-10-(hydroxymethyl)-6-oxo-12-(1,3-thiazol-2-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate

C17H19N3O4S (361.1096)


   

2-[(2R,5S,6R)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]acetic acid methyl ester

2-[(2R,5S,6R)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]acetic acid methyl ester

C15H20FNO6S (361.0995)


   

2-[(2R,5R,6R)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]acetic acid methyl ester

2-[(2R,5R,6R)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]acetic acid methyl ester

C15H20FNO6S (361.0995)


   

2-[(2S,5R,6R)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]acetic acid methyl ester

2-[(2S,5R,6R)-5-[(2-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]acetic acid methyl ester

C15H20FNO6S (361.0995)


   

Ethyl 4-(4-hydroxyphenyl)-2-methyl-5-oxo-3,4-dihydroindeno[1,2-b]pyridine-3-carboxylate

Ethyl 4-(4-hydroxyphenyl)-2-methyl-5-oxo-3,4-dihydroindeno[1,2-b]pyridine-3-carboxylate

C22H19NO4 (361.1314)


   

[(2E)-2-{(2E)-[(1,3-dimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)methylidene]hydrazinylidene}-4-oxo-1,3-thiazolidin-5-yl]acetic acid

[(2E)-2-{(2E)-[(1,3-dimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)methylidene]hydrazinylidene}-4-oxo-1,3-thiazolidin-5-yl]acetic acid

C15H15N5O4S (361.0845)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

1-S-[(1Z)-N-(sulfooxy)butanimidoyl]-1-thio-beta-D-glucopyranose

1-S-[(1Z)-N-(sulfooxy)butanimidoyl]-1-thio-beta-D-glucopyranose

C10H19NO9S2 (361.0501)


   

(5E)-2-(3,4-dimethylphenyl)imino-5-[(1-methylindol-3-yl)methylidene]-1,3-thiazolidin-4-one

(5E)-2-(3,4-dimethylphenyl)imino-5-[(1-methylindol-3-yl)methylidene]-1,3-thiazolidin-4-one

C21H19N3OS (361.1249)


   

5-(1-Methylpiperidin-2-yl)-2,3-bipyridine trihydrochloride

5-(1-Methylpiperidin-2-yl)-2,3-bipyridine trihydrochloride

C16H22Cl3N3 (361.0879)


   

(3R)-4-(Methoxymethyl-thio)-3-(N-methoxymethyl-N-tosyl)aminobutan-2-one

(3R)-4-(Methoxymethyl-thio)-3-(N-methoxymethyl-N-tosyl)aminobutan-2-one

C15H23NO5S2 (361.1018)


   

3-[(Diethoxyphosphinyl)methyl]-5-(phenylsulfonyl)-2-isoxazoline

3-[(Diethoxyphosphinyl)methyl]-5-(phenylsulfonyl)-2-isoxazoline

C14H20NO6PS (361.0749)


   

1,2-Di(methoxycarbonyl)-5-phenyl-3H-pyrrolo[2,1,5-de]quinolizin-3-one

1,2-Di(methoxycarbonyl)-5-phenyl-3H-pyrrolo[2,1,5-de]quinolizin-3-one

C21H15NO5 (361.095)


   

PYRIMINOBAC-METHYL

(e)-pyriminobac-methyl

C17H19N3O6 (361.1274)


   

5-hydroxyomeprazole

5-hydroxyomeprazole

C17H19N3O4S (361.1096)


A sulfoxide that is omeprazole in which one of the methyl hydrogens at position 5 on the pyridine ring is substituted by a hydroxy group.

   

Nitroflurbiprofen

Nitroflurbiprofen

C19H20FNO5 (361.1325)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor

   
   

2-methyladenosine 5-monophosphate

2-methyladenosine 5-monophosphate

C11H16N5O7P (361.0787)


A purine ribonucleoside 5-monophosphate having 2-methyladenine as the nucleobase.

   

propylglucosinolic acid

propylglucosinolic acid

C10H19NO9S2 (361.0501)


An alkylglucosinolic acid that consists of 1-thio-beta-D-glucopyranose attached to a N-(sulfooxy)butanimidoyl group at the anomeric sulfur.

   

HIF-1α-IN-2

HIF-1α-IN-2

C21H19N3OS (361.1249)


HIF-1α-IN-2 is an effective HIF-1α inhibitor with anticancer potencies (IC50s of 28 nM and 15 nM in MDA-MB-231 and MiaPaCa-2 cells, respectively). HIF-1α-IN-2?suppresses HIF-1α expression by blocking transcription and?protein translation[1].

   

(2s)-5-carbamimidamido-2-[2-(6-hydroxy-1h-indol-3-yl)-2-oxoacetamido]pentanoic acid

(2s)-5-carbamimidamido-2-[2-(6-hydroxy-1h-indol-3-yl)-2-oxoacetamido]pentanoic acid

C16H19N5O5 (361.1386)


   

1,2-dimethyl (1r,2s)-1,2-dimethoxy-3-methyl-8-oxocyclobuta[b]quinoline-1,2-dicarboxylate

1,2-dimethyl (1r,2s)-1,2-dimethoxy-3-methyl-8-oxocyclobuta[b]quinoline-1,2-dicarboxylate

C18H19NO7 (361.1161)


   

[(2-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

[(2-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

C10H19NO9S2 (361.0501)


   

(2r,3r,4s,5s,6r)-2-({6-[(z)-(hydroxyimino)methyl]-[2,2'-bipyridin]-4-yl}oxy)-6-methyloxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-({6-[(z)-(hydroxyimino)methyl]-[2,2'-bipyridin]-4-yl}oxy)-6-methyloxane-3,4,5-triol

C17H19N3O6 (361.1274)


   

1,2-dimethyl 1,2-dimethoxy-3-methyl-8-oxocyclobuta[b]quinoline-1,2-dicarboxylate

1,2-dimethyl 1,2-dimethoxy-3-methyl-8-oxocyclobuta[b]quinoline-1,2-dicarboxylate

C18H19NO7 (361.1161)


   

2-[4-hydroxy-2-methoxy-6-(methoxycarbonyl)phenoxy]-6-methoxy-4-methylbenzenecarboximidic acid

2-[4-hydroxy-2-methoxy-6-(methoxycarbonyl)phenoxy]-6-methoxy-4-methylbenzenecarboximidic acid

C18H19NO7 (361.1161)


   

n-[2-hydroxy-4-(methoxycarbonyl)phenyl]-2,3,4-trimethoxybenzenecarboximidic acid

n-[2-hydroxy-4-(methoxycarbonyl)phenyl]-2,3,4-trimethoxybenzenecarboximidic acid

C18H19NO7 (361.1161)


   

6-(1-{[2-aminoethoxy(hydroxy)phosphoryl]oxy}-2-hydroxyethyl)-2,4,5-trihydroxyoxane-2-carboxylic acid

6-(1-{[2-aminoethoxy(hydroxy)phosphoryl]oxy}-2-hydroxyethyl)-2,4,5-trihydroxyoxane-2-carboxylic acid

C10H20NO11P (361.0774)


   

7-carbomethoxyevodiamine

NA

C21H19N3O3 (361.1426)


{"Ingredient_id": "HBIN013131","Ingredient_name": "7-carbomethoxyevodiamine","Alias": "NA","Ingredient_formula": "C21H19N3O3","Ingredient_Smile": "NA","Ingredient_weight": "361.39","OB_score": "NA","CAS_id": "69754-01-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7463","PubChem_id": "NA","DrugBank_id": "NA"}

   

7-chloro-(2r)-2-o-β-d-glucopyranosyl-2h-1,4-benzoxazin-3(4h)-one

NA

C14H16ClNO8 (361.0564)


{"Ingredient_id": "HBIN013136","Ingredient_name": "7-chloro-(2r)-2-o-\u03b2-d-glucopyranosyl-2h-1,4-benzoxazin-3(4h)-one","Alias": "NA","Ingredient_formula": "C14H16ClNO8","Ingredient_Smile": "C1=CC2=C(C=C1Cl)OC(C(=O)N2)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3554","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

7,9,9-trimethoxy-13-methyl-10-azapentacyclo[9.7.1.0²,¹⁰.0³,⁸.0¹⁵,¹⁹]nonadeca-1,3(8),4,6,11,13,15(19),16-octaen-18-one

7,9,9-trimethoxy-13-methyl-10-azapentacyclo[9.7.1.0²,¹⁰.0³,⁸.0¹⁵,¹⁹]nonadeca-1,3(8),4,6,11,13,15(19),16-octaen-18-one

C22H19NO4 (361.1314)


   

(3s,4r)-5-hydroxy-3,4-bis(6-hydroxy-1h-indol-3-yl)-3,4-dihydropyrrol-2-one

(3s,4r)-5-hydroxy-3,4-bis(6-hydroxy-1h-indol-3-yl)-3,4-dihydropyrrol-2-one

C20H15N3O4 (361.1063)


   

3-[2-(dimethylamino)-4-hydroxypteridin-6-yl]-2,3-dihydroxypropoxyphosphonic acid

3-[2-(dimethylamino)-4-hydroxypteridin-6-yl]-2,3-dihydroxypropoxyphosphonic acid

C11H16N5O7P (361.0787)


   

2-[(1z,2s,3s,4s,6r)-2,4-dihydroxy-3-methoxy-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexylidene]acetonitrile

2-[(1z,2s,3s,4s,6r)-2,4-dihydroxy-3-methoxy-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexylidene]acetonitrile

C15H23NO9 (361.1373)


   

[(z)-(2-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

[(z)-(2-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

C10H19NO9S2 (361.0501)


   

5-hydroxy-3,4-bis(6-hydroxy-1h-indol-3-yl)-3,4-dihydropyrrol-2-one

5-hydroxy-3,4-bis(6-hydroxy-1h-indol-3-yl)-3,4-dihydropyrrol-2-one

C20H15N3O4 (361.1063)


   

1,6-dihydroxy-2,3,4,5-tetramethoxy-10-methylacridin-9-one

1,6-dihydroxy-2,3,4,5-tetramethoxy-10-methylacridin-9-one

C18H19NO7 (361.1161)


   

methyl 1-methyl-4-oxo-2-(1,2,3-trimethoxy-3-oxoprop-1-en-1-yl)quinoline-3-carboxylate

methyl 1-methyl-4-oxo-2-(1,2,3-trimethoxy-3-oxoprop-1-en-1-yl)quinoline-3-carboxylate

C18H19NO7 (361.1161)


   

17,18-dimethoxy-21-methyl-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1,3,5,7,9,15(20),16,18-octaen-14-one

17,18-dimethoxy-21-methyl-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1,3,5,7,9,15(20),16,18-octaen-14-one

C21H19N3O3 (361.1426)


   

7-hydroxy-9-(5-hydroxy-1h-indol-3-yl)-3,10-diazatricyclo[6.4.1.0⁴,¹³]trideca-1,4,6,8(13),9-pentaene-11-carboxylic acid

7-hydroxy-9-(5-hydroxy-1h-indol-3-yl)-3,10-diazatricyclo[6.4.1.0⁴,¹³]trideca-1,4,6,8(13),9-pentaene-11-carboxylic acid

C20H15N3O4 (361.1063)


   

(2e)-3-(2,4-dihydroxy-6-methylpyrimidin-5-yl)-n-[1-hydroxy-3-(methylsulfanyl)methanesulfinylpropan-2-yl]prop-2-enimidic acid

(2e)-3-(2,4-dihydroxy-6-methylpyrimidin-5-yl)-n-[1-hydroxy-3-(methylsulfanyl)methanesulfinylpropan-2-yl]prop-2-enimidic acid

C13H19N3O5S2 (361.0766)


   

(2s,3r,5s)-2-(hydroxymethyl)-5-[4-(phenanthren-9-yl)-1,2,3-triazol-1-yl]oxolan-3-ol

(2s,3r,5s)-2-(hydroxymethyl)-5-[4-(phenanthren-9-yl)-1,2,3-triazol-1-yl]oxolan-3-ol

C21H19N3O3 (361.1426)


   

5-carbamimidamido-2-[2-(6-hydroxy-1h-indol-3-yl)-2-oxoacetamido]pentanoic acid

5-carbamimidamido-2-[2-(6-hydroxy-1h-indol-3-yl)-2-oxoacetamido]pentanoic acid

C16H19N5O5 (361.1386)


   

n-[(3z,14z)-1,1,15-trichloropentadeca-1,3,14-trien-12-yn-8-yl]ethanimidic acid

n-[(3z,14z)-1,1,15-trichloropentadeca-1,3,14-trien-12-yn-8-yl]ethanimidic acid

C17H22Cl3NO (361.0767)


   

(11r)-7-hydroxy-9-(5-hydroxy-1h-indol-3-yl)-3,10-diazatricyclo[6.4.1.0⁴,¹³]trideca-1,4,6,8(13),9-pentaene-11-carboxylic acid

(11r)-7-hydroxy-9-(5-hydroxy-1h-indol-3-yl)-3,10-diazatricyclo[6.4.1.0⁴,¹³]trideca-1,4,6,8(13),9-pentaene-11-carboxylic acid

C20H15N3O4 (361.1063)


   

methyl (2r)-3'-amino-5-hydroxy-4'-methoxy-7-methyl-4,6'-dioxospiro[1,3-benzodioxine-2,1'-cyclohexane]-2',4'-diene-2'-carboxylate

methyl (2r)-3'-amino-5-hydroxy-4'-methoxy-7-methyl-4,6'-dioxospiro[1,3-benzodioxine-2,1'-cyclohexane]-2',4'-diene-2'-carboxylate

C17H15NO8 (361.0798)


   

methyl (2r)-5'-amino-5-hydroxy-2'-methoxy-7-methyl-4,4'-dioxospiro[1,3-benzodioxine-2,1'-cyclohexane]-2',5'-diene-6'-carboxylate

methyl (2r)-5'-amino-5-hydroxy-2'-methoxy-7-methyl-4,4'-dioxospiro[1,3-benzodioxine-2,1'-cyclohexane]-2',5'-diene-6'-carboxylate

C17H15NO8 (361.0798)


   

(2s,4r,5r,6s)-6-[(1s)-1-{[2-aminoethoxy(hydroxy)phosphoryl]oxy}-2-hydroxyethyl]-2,4,5-trihydroxyoxane-2-carboxylic acid

(2s,4r,5r,6s)-6-[(1s)-1-{[2-aminoethoxy(hydroxy)phosphoryl]oxy}-2-hydroxyethyl]-2,4,5-trihydroxyoxane-2-carboxylic acid

C10H20NO11P (361.0774)


   

(2e)-3-(2,4-dihydroxy-6-methylpyrimidin-5-yl)-n-[(2s)-1-hydroxy-3-[(r)-(methylsulfanyl)methanesulfinyl]propan-2-yl]prop-2-enimidic acid

(2e)-3-(2,4-dihydroxy-6-methylpyrimidin-5-yl)-n-[(2s)-1-hydroxy-3-[(r)-(methylsulfanyl)methanesulfinyl]propan-2-yl]prop-2-enimidic acid

C13H19N3O5S2 (361.0766)


   

(2r,3r,4r,5s,6s)-3,4,5-trihydroxy-6-[(2r)-2-hydroxy-3-(1h-pyrrole-2-carbonyloxy)propoxy]oxane-2-carboxylic acid

(2r,3r,4r,5s,6s)-3,4,5-trihydroxy-6-[(2r)-2-hydroxy-3-(1h-pyrrole-2-carbonyloxy)propoxy]oxane-2-carboxylic acid

C14H19NO10 (361.1009)


   

(2r)-5-carbamimidamido-2-[2-(6-hydroxy-1h-indol-3-yl)-2-oxoacetamido]pentanoic acid

(2r)-5-carbamimidamido-2-[2-(6-hydroxy-1h-indol-3-yl)-2-oxoacetamido]pentanoic acid

C16H19N5O5 (361.1386)


   

methyl 1-methyl-4-oxo-2-[(1z)-1,2,3-trimethoxy-3-oxoprop-1-en-1-yl]quinoline-3-carboxylate

methyl 1-methyl-4-oxo-2-[(1z)-1,2,3-trimethoxy-3-oxoprop-1-en-1-yl]quinoline-3-carboxylate

C18H19NO7 (361.1161)


   

1,2-dimethyl (1r,2r)-1,2-dimethoxy-3-methyl-8-oxocyclobuta[b]quinoline-1,2-dicarboxylate

1,2-dimethyl (1r,2r)-1,2-dimethoxy-3-methyl-8-oxocyclobuta[b]quinoline-1,2-dicarboxylate

C18H19NO7 (361.1161)


   

[(2-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

[(2-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

C10H19NO9S2 (361.0501)


   

2-[(1e,2s,3r,4s,6r)-2,3-dihydroxy-4-methoxy-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexylidene]acetonitrile

2-[(1e,2s,3r,4s,6r)-2,3-dihydroxy-4-methoxy-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexylidene]acetonitrile

C15H23NO9 (361.1373)


   

1,6,7-trimethoxy-n,n-dimethyl-8-(methyldisulfanyl)-3,4-dihydro-1h-2-benzothiopyran-5-amine

1,6,7-trimethoxy-n,n-dimethyl-8-(methyldisulfanyl)-3,4-dihydro-1h-2-benzothiopyran-5-amine

C15H23NO3S3 (361.084)


   

4-[(2,2-dimethylchromen-6-yl)methyl]-5-hydroxy-3-(4-hydroxyphenyl)pyrrol-2-one

4-[(2,2-dimethylchromen-6-yl)methyl]-5-hydroxy-3-(4-hydroxyphenyl)pyrrol-2-one

C22H19NO4 (361.1314)


   

(2s,3s)-3-[2-(dimethylamino)-4-hydroxypteridin-6-yl]-2,3-dihydroxypropoxyphosphonic acid

(2s,3s)-3-[2-(dimethylamino)-4-hydroxypteridin-6-yl]-2,3-dihydroxypropoxyphosphonic acid

C11H16N5O7P (361.0787)


   

18-methoxy-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17,20-nonaen-17-yl acetate

18-methoxy-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17,20-nonaen-17-yl acetate

C21H15NO5 (361.095)


   

(2e)-3-(2,4-dihydroxy-6-methylpyrimidin-5-yl)-n-{1-hydroxy-3-[(r)-(methylsulfanyl)methanesulfinyl]propan-2-yl}prop-2-enimidic acid

(2e)-3-(2,4-dihydroxy-6-methylpyrimidin-5-yl)-n-{1-hydroxy-3-[(r)-(methylsulfanyl)methanesulfinyl]propan-2-yl}prop-2-enimidic acid

C13H19N3O5S2 (361.0766)


   

2-({6-[(hydroxyimino)methyl]-[2,2'-bipyridin]-4-yl}oxy)-6-methyloxane-3,4,5-triol

2-({6-[(hydroxyimino)methyl]-[2,2'-bipyridin]-4-yl}oxy)-6-methyloxane-3,4,5-triol

C17H19N3O6 (361.1274)


   

(11s)-7-hydroxy-9-(5-hydroxy-1h-indol-3-yl)-3,10-diazatricyclo[6.4.1.0⁴,¹³]trideca-1,4,6,8(13),9-pentaene-11-carboxylic acid

(11s)-7-hydroxy-9-(5-hydroxy-1h-indol-3-yl)-3,10-diazatricyclo[6.4.1.0⁴,¹³]trideca-1,4,6,8(13),9-pentaene-11-carboxylic acid

C20H15N3O4 (361.1063)


   

[(e)-(2-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

[(e)-(2-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

C10H19NO9S2 (361.0501)